Starbucks Corporation (SBUX) a Brief History of Success

On March 30, 1971 the first Starbucks Corporation’s (NASDAQ:SBUX) shop opens in Seattle, Washington, and since then it has been constantly growing worldwide. The green mermaid logo can now be seen in different countries around the world, and also on numerous instances on the web. A CNBC report has been dedicated to inform about its progress so far.

Starbucks Corporation (NASDAQ:SBUX)

Starbucks Corporation’s (NASDAQ:SBUX)’s Initial Public Offering took place in June 1992 and if one had invested $1,000 in the company’s stock, the stake would have amounted to about $6 million, affirms a report on MSN Money. It is easy to calculate post factum what a savvy investor must have pursued, yet at that time it was unclear whether a mid-sized business like  Starbucks Corporation (NASDAQ:SBUX) at that point would have survived on the market. It did, and better than expected.

In 1999, the company acquired Tazo Tea, diversifying into the beverages market. It took one takeover, from just coffee to a full range of drinks. But there’s more, as the company continued to experiment with new products, thus in 2003 the Pumpkin Spice Latte was first seen in the menu, broadening the range of offered products. Also, to keep in pace with the constantly evolving technology and payment methods, Starbucks Corporation (NASDAQ:SBUX) introduced mobile payment in 2009, allowing customers to purchase drinks with solely their phone.

As things got more Internet-related, the company launched Tweet-A-Coffee in 2013, to further spur its popularity among the clients. And with Instagram and Facebook pages constantly updated, Starbucks Corporation (NASDAQ:SBUX) established itself as a fully proven entity in both real and virtual life.

Currently, Starbucks Corporation (NASDAQ:SBUX) has more than 21,000 shops, spread across 65 countries,  it’s craving dominance in the franchise sphere. Competition is tough, but the company is doing well and showing an impressive growth for the last couple of years. Nevertheless, it has reached or almost reached maturity and the perspectives aren’t evident. If it will find some way to boost its stock price as sharply as historically recorded, investors will be more than delighted.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!